https://medicalxpress.com/news/2020-05-india-hydroxychloroquine-virus.html https://medicalxpress.com/news/2020-05-india-hydroxychloroqu... Observational and ca

https://medicalxpress.com/news/2020-05-india-hydroxychloroquine-virus.html https://medicalxpress.com/news/2020-05-india-hydroxychloroqu... Observational and case control studies in India showed there were "no major side effects" of taking the drug as a prophylactic, ICMR Director-General Balram Bhargava said. Cases of nausea, vomiting and heart palpitations were noted, he added. Last week, the ICMR—which is leading the government's response to the virus—expanded its advisory for the use of hydroxychloroquine as a preventative measure. The body said all healthcare workers in hospitals and some frontline personnel could now take the drug for up to several weeks under strict medical supervision. "We recommended that for prophylaxis, it should be continued, because there is no harm. Benefit may be there," Bhargava told reporters. Bhargava added that when the ICMR weighed the risks and benefits of the drug, it decided that "we should not deny it to our frontline workers and healthcare workers."